Alkylating Agents: Clinical Trials

1 trial of Alkylating Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Alkylating Agents: new trials by email Literature Review of Alkylating Agents trials Research Report on Alkylating Agents

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multicenter Uveitis Steroid Treatment (MUST) Trial
fluocinolone acetonide intraocular implant, oral corticosteroid with immunosuppressive agents as needed - Uveitis
Phase 4CompletedJHSPH Center for Clinical Trials2552005-09-012016-11-25

Conditions studied

Uveitis (1)

Sponsors

JHSPH Center for Clinical Trials (1)

Countries

Australia (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Douglas Jabs, MD, MBA (1)  ·  Janet T Holbrook, PhD, MPH (1)  ·  John Kempen, MD, PhD (1)  ·  Michael Altaweel, MD (1)

Results publications

PMID 21652026, PMID 21840602, PMID 21861971, PMID 22247489, PMID 22409563, PMID 23163490, PMID 25115882, PMID 26501236, PMID 26798977, PMID 28477440, PMID 32918964

NIH funding

U10EY014660 (1)